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Heterozygous mutations of the tissue-specific transcription
factor hepatocyte nuclear factor (HNF)1b, cause maturity
onset diabetes of the young (MODY5) and kidney anomalies
including agenesis, hypoplasia, dysplasia and cysts. Because
of these renal anomalies, HNF1b is classified as a CAKUT
(congenital anomalies of the kidney and urinary tract) gene.
We searched for human fetal kidney proteins interacting with
the N-terminal region of HNF1b using a bacterial two-hybrid
system and identified five novel proteins along with the
known partner DCoH. The interactions were confirmed for
four of these proteins by GST pull-down assays.
Overexpression of two proteins, E4F1 and ZFP36L1, in
Xenopus embryos interfered with pronephros formation.
Further, in situ hybridization showed overlapping expression
of HNF1b, E4F1 and ZFP36L1 in the developing pronephros.
HNF1b is present largely in the nucleus where it colocalized
with E4F1. However, ZFP36L1 was located predominantly in
the cytoplasm. A nuclear function for ZFP36L1 was shown as
it was able to reduce HNF1b transactivation in a luciferase
reporter system. Our studies show novel proteins may
cooperate with HNF1b in human metanephric development
and propose that E4F1 and ZFP36L1 are CAKUT genes. We
searched for mutations in the open reading frame of the
ZFP36L1 gene in 58 patients with renal anomalies but found
none.
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In humans, heterozygous mutations of the TCF2 gene
encoding the hepatocyte nuclear factor (HNF)1b result in
several kidney abnormalities, including formation of cysts,
oligomeganephronia, renal agenesis, renal hypoplasia, and
familial juvenile hyperuricemic nephropathy. In addition,
mutation carriers have a variety of extrarenal phenotypes,
such as maturity onset diabetes of the young (MODY5),
malformations of the genital tract, gout, deranged liver
function, and pancreatic atrophy.1 As heterozygous deletions
of the TCF2 gene2–4 have an equivalent phenotype to
mutations, it is likely that an impaired gene dosage is the
causative factor for the HNF1b-associated diseases.
HNF1b is a homeodomain-containing transcription factor
expressed in the liver, pancreas, gut, lung, genital tract, and
kidney.5,6 It also has a function in early embryogenesis, as
HNF1b-null mice die before gastrulation due to the failure of
proper differentiation of the visceral endoderm.7,8 The rescue
of this early lethality by tetraploid aggregation results in
pancreas agenesis,9 whereas by using tissue-restricted knock-
outs, the differential function of HNF1b in the liver,10
pancreatic b-cells,11 and in the kidney12 could be identified.
All these tissue-specific defects in mice reflect the human
diseases observed in patients with heterozygous HNF1b
mutations. Notably, the kidney-specific knockout of HNF1b
revealed the defective activation of the UMOD, PKHD1, and
PKD2 genes whose mutations are responsible for distinct
kidney defects in humans.12 A link between HNF1b and the
PKHD1 gene that is mutated in humans with autosomal-
recessive polycystic kidney disease was also established by
kidney-specific overexpression of an HNF1b mutant leading
to renal cysts.13 Based on studies in mice with a kidney-
restricted knockout of HNF1b, it has been concluded that the
tubular enlargement and cyst formation are triggered by a
disruption of the association of mitotic cell orientation along
the tubule axis.14
As the structure and function of HNF1b is highly
conserved in vertebrates, lower vertebrates are informative
models for HNF1b function. In fact, mutations in the
zebrafish HNF1b gene result in phenotypes closely related to
the human diseases including kidney cysts as well as
underdevelopment of the pancreas and the liver.15 In the
Xenopus, we have previously shown that overexpression of
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human HNF1b mutants leads to a reduction or enlargement
of the pronephros size depending on the mutant type
injected.16,17 The pronephros is the functional kidney of
Xenopus larvae, which is the simplest form of the three types
of kidneys in vertebrates. It consists of only one nephron,
which is the functional unit in the meso- and metanephros as
well. Therefore, the Xenopus pronephros is an excellent organ
system to identify the nephrogenic gene network, which
undoubtedly has applicability to human kidney develop-
ment.18–20
HNF1b is a member of the group of genes responsible for
congenital anomalies of the kidney and urinary tract
(CAKUT), which cause 40% of renal insufficiency or end-
stage renal failure of children.21 However, in most CAKUT
patients (75–90%), the defective gene expression has yet to be
identified.1,22,23 Assuming that genes coding for protein
interaction partners of HNF1b are potential CAKUT genes,
we search in this report for interaction partners of HNF1b
using a two-hybrid system. To validate proteins interacting
with HNF1b, we tested their function in cell cultures and
defined their biological relevance for kidney formation via
overexpression in Xenopus larvae. Based on these experi-
ments, we propose that ZFP36L1 and E4F1 are genes whose
dysfunction may lead to kidney malformations in humans.
RESULTS
Identification of interaction partners of HNF1b
To identify interaction partners of HNF1b, we used the
bacterial two-hybrid system BacteriomatchII (Stratagene,
La Jolla, CA, USA). Identification of interaction is based on
transcriptional activation of reporter genes mediated by
interaction of the fusion proteins containing either the bait
or the target (Figure 1a). The bait is fused to the l-repressor
lcl that recognizes the operator sequence in the promoter,
whereas the target sequence is linked to the RNA polymerase.
When bait and target interact, RNA polymerase is recruited
to the promoter and transcription of the reporter genes is
initiated. As bait, we cloned downstream of the l-repressor
lcl the N-terminal region of human HNF1b (HNF1bbb in
Figure 1b), which contains the region of HNF1b conferring
defective pronephros development in Xenopus.24 A control
experiment revealed that HNF1bbb linked to lcl did not self-
activate the transcription of the reporter genes in the
bacterial system. As targets, we used a human fetal kidney
cDNA library fused to the DNA encoding the a-subunit of
RNA polymerase. By cotransformation of the bait vector with
the target cDNA library, we screened 1.5 million transfor-
mants for interaction. After validation and exclusion of self-
activation by the target proteins, 138 candidates remained for
sequence analysis. We obtained eight distinct protein
sequences with more than 20 amino acids fused in frame
to the RNA polymerase a-subunit (Table 1). Whereas the
open reading frame (ORF) of dimerization cofactor of HNF1
(DcoH) was recovered as full length, all the other ORFs
represented a C-terminal fragment. This reflects that the
kidney cDNA library was oligodT primed and had an average
length of only 1.39 kb. Six proteins could be identified as the
bona fide proteins DAK, PCBD1, E4F1, HADH, TRIM26, and
ZFP36L1, whereas C17orf45 represents only a protein
predicted by the ORF. As no cDNA was available for
C17orf45, the analysis of this potential interaction partner
was not further pursued. As PCBD1, also known as DCoH, is
a well-known interaction partner of HNF1b ,25 but plays no
role in nephrogenesis,26,27 we excluded it from further
investigation.
To verify the interaction with HNF1b for the five
remaining proteins, we made an in vitro GST pull-down
assay. We produced the five full-length proteins as myc-
tagged versions in a rabbit reticulocyte system and incubated
the lysates in vitro with the purified GST–HNF1bbb fusion
protein produced in Escherichia coli. Interaction could be
confirmed for the proteins E4F1, HADH, TRIM26, and
ZFP36L1, whereas DAK did not interact and thus was not
investigated further (Figure 2). TRIM26 seems to be a weak
interactor, as interaction was only observed in an incubation
buffer with 50 mM NaCl.
E4F1 and ZFP36L1 interfere with nephrogenesis in Xenopus
embryos
To elucidate a potential nephrogenic role of the HNF1b
interaction partners, we expressed the myc-tagged proteins in
Xenopus embryos. RNAs encoding the human proteins were
coinjected with RNA encoding green fluorescent protein
(GFP) into one blastomere of Xenopus laevis two-cell-stage
embryos. Proper translation of the interaction partners in
Xenopus embryos was proven by Western blots of injected
larvae using an anti-myc antibody (data not shown). Using
GFP fluorescence, the injected side of the tailbud-stage
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Figure 1 | Two-hybrid system components. (a). The reporter
genes HIS3 and aadA are driven by a promoter whose activity is
dependent on the interaction of RNA polymerase (RNAP) with the
lcl repressor bound to the operator. The interaction is mediated
by protein–protein contact of the bait and the target linked to the
repressor and the polymerase, respectively. The target proteins
are encoded by the commercial human oligodT primed cDNA
library derived from kidneys of five male fetuses, 17–28 weeks
after gestation (Stratagene). (b) Schematic drawing of the human
HNF1b protein with the dimerization (dim.) domain, the DNA-
binding domains POUS and POUH as well as the transactivation
domain. The bracket indicates the N-terminal portion containing
the nephrogenic domains (HNF1bbb) used as bait.
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embryo (stage 2628) was recorded, and in the swimming
tadpole (stage 45), the pronephric tubule and duct were
visualized by immunostaining using the pronephros-specific
antibodies 3G8 and 4A6.29 In each tadpole, we compared the
pronephros of the injected side with the uninjected side.
Firstly, we compared the size of the manipulated pronephros
using tadpoles only injected with GFP as a reference. As
shown in Figure 3a, overexpression of E4F1 leads to a
significant increase of 21% in the pronephros size, whereas
TRIM26 or ZFP36L1 overexpressions result in a significantly
smaller pronephros (3.5 and 10%, respectively). In
contrast, the introduction of HADH had no effect.
As a second criterion, we investigated the structure of the
tubule and the duct. Figure 3b documents that the increase of
the pronephros size in E4F1-injected embryos reflects either a
thickening of the duct (animal 1) or a lengthening of the
tubule (animal 2). In contrast, overexpression of HADH
failed to alter the morphology of the pronephros (data not
shown). As there was also no effect on the size of the
pronephros (Figure 3a), we conclude that HADH over-
expression does not interfere with pronephros formation.
Analyzing TRIM26-injected tadpoles, we could not detect any
structural abnormality of the pronephros (Figure 3c, animal
3). For this reason and because no homolog of TRIM26 is
known in lower vertebrates, this interaction partner was not
analyzed further. Overexpression of ZFP36L1 dramatically
affected the structural integrity of the pronephros. Figure 3d
illustrates that the phenotype of the pronephros was quite
variable. In some cases, a large cyst was present (animal 5),
whereas in others a thickening of the tubule predominated
(animal 6) or a rudimentary organ was present (animal 7).
This heterogeneity of the pronephros structure is reflected in
the variable pronephros size of the ZFP36L1-injected tadpoles
(Figure 3a). In conclusion, E4F1 as well as ZFP36L1
overexpressions induce pronephros abnormality in Xenopus.
Localization of E4F1 and ZFP36L1 in the developing Xenopus
embryo
To test whether E4F1 and ZFP36L1 are indeed expressed
during organogenesis in Xenopus pronephros, we performed
whole-mount in situ hybridizations using the Xenopus
homologs of these two factors. In the neurula stage when
HNF1b expression was mainly restricted to the pronephros
anlage as reported previously,30 the transcripts of E4F1 and
ZFP36L1 were broadly expressed with hardly any overlap
with the pronephros anlage (Figure 4a, left panels). However,
both transcripts were localized in the developing pronephros
of the tailbud-stage embryo (Figure 4a, right panel). In
Table 1 | Potential interaction partners of HNF1b
Official symbol Common names
Protein part
(amino acids) Function Chromosomal location
C17orf45 Chromosome 17 open reading frame 24 of 131 Hypothetical protein 17p11.2
DAK Dihydroxyacetone kinase 2 93 of 575 Glycerone (dihydroxyacetone)
kinase activity
11q12.2
PCBD1 (DCoH) Pterin-4 a-carbinolamine dehydratase
(dimerization cofactor of HNF1)
1–104 (full
length)
Metabolic enzyme, dimerization
cofactor of HNF1
10q22
E4F1 E4F transcription factor 1 497 of 785 Cell cycle progression, transcriptional
repressor
16p13.3 90 kb upstream of PKD1
(polycystic kidney disease 1)
HADH Hydroxyacyl-CoA dehydrogenase,
isoform 2
354 of 381 Mitochondrial fatty acid b-oxidation,
mutation causes congenital
hyperinsulinism
4q22–q26
TRIM26, isoform
CRA_C
Tripartite motif-containing 26
(zinc finger protein 173)
36 of 109 RING finger protein, potential
protein–protein interaction and
ubiquitination
6p21.3
ZFP36L1 (BRF1) Zinc-finger protein 36 C3H type-like 1
(butyrate response factor 1)
55 of 338 Destabilization of mRNA by binding
AU-rich sequences
14q22–q24
The protein part refers to the length of the C-terminal protein sequence of the full-length protein found in the fusion protein. Exactly the same clone was recovered twice
independently for TRIM26.
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Figure 2 | Four candidates interact with HNF1bbb in GST pull-
down assays. Full-length interaction partners with an N-terminal
myc-tag were produced in a rabbit reticulocyte system (TNT,
Promega) and incubated with the recombinant GST–HNF1bbb
fusion protein bound to glutathione sepharose beads. After
washing, proteins were recovered and detected by 9E10 mouse
anti-myc antibody in Western blots. As controls, GST bound to
sepharose or sepharose alone were used.
212 Kidney International (2008) 74, 210–217
o r i g i n a l a r t i c l e K Dudziak et al.: Interaction partners of HNF1b
contrast to HNF1b, whose expression was most prominent in
the pronephros, E4F1 and ZFP36L1 were expressed in various
parts of the embryo. These broad expression patterns
represent specific hybridizations, as in situ hybridizations
using the sense probes gave essentially no signals (Figure 4b).
Thus, it seems likely that HNF1b cooperates with E4F1 and
ZFP36L1 when pronephros differentiation has initiated.18,19
Cellular localization of E4F1 and ZFP36L1
Confirmation of protein–protein interaction in vivo requires
the availability of specific and highly sensitive antibodies that
were not available for E4F1 and ZFP36L1. Therefore, we
limited our analysis to transfected HEK293 cells that allowed
the use of myc-tagged transcription factors in coimmuno-
precipitation. However, we could not get any conclusive
results, as the HNF1b antibodies were not specific enough
and E4F1 itself attached to the A/G-agarose.
To test whether HNF1b and the interaction partners E4F1
or ZFP36L1 reside in the same cellular compartments, we
analyzed the cellular localization of E4F1 or ZFP36L1
together with HNF1b in the human embryonic kidney cell
line HEK293. The HNF1b sequence was fused to the GFP
sequence, whereas the interaction partners were used as myc-
tagged proteins. As illustrated in Figure 5, cotransfected E4F1
and HNF1b are both located in the nucleus exhibiting a very
similar dot-like structure. The same nuclear localization was
seen for each protein when transfected separately, indicating
their constitutive nuclear function (data not shown). In
contrast, ZFP36L1 was predominantly present in the
cytoplasm (Figure 5), irrespective of whether expressed alone
(data not shown) or coexpressed with HNF1b that was
always nuclear (Figure 5). Varying the ratio of transfected
DNA of both factors from 1:3 to 3:1 did not influence their
localization. However, the overlay of the myc and GFP
picture (Figure 5) suggests some colocalization of ZFP36L1
and HNF1b at the nuclear membrane.
ZFP36L1 reduces the transactivation potential of HNF1b
To monitor whether E4F1 or ZFP36L1 affect the transcrip-
tional function of HNF1b, we measured their influence in
luciferase reporter assays in the presence of HNF1b. As
reporter constructs, we selected the osteopontin (OPN)
promoter known to be regulated by HNF1b in HEK293
cells31 as well as the Ksp-cadherin promoter reported to be
under HNF1b control in early nephrogenesis.32 Figure 6a
illustrates that HNF1b activates the osteopontin and Ksp-
cadherin promoter as expected. The addition of E4F1 reduced
the activation of the osteopontin promoter mediated by
HNF1b. However, this effect does not necessarily reveal an
interaction between HNF1b and E4F1, as the basal activity of
the osteopontin promoter is decreased by E4F1 alone.
Similarly, on the Ksp-cadherin promoter, E4F1 activates
the reporter on its own and therefore the meaning of the
further activation found together with HNF1b cannot be
attributed conclusively to an interaction. As the osteopontin
and Ksp-cadherin promoters contain binding sites for many
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Figure 3 | Influence of overexpressed HNF1b interaction
partners on pronephros development in Xenopus larvae.
(a) The size of pronephros on injected versus control side is given.
The size was determined in lateral views by measuring the area
through the widest part of the immunostained pronephros as
described.17 Data were tested for Gaussian distribution and
accordingly the Student’s t-test was used to score significant
differences. The P-value is given by comparing embryos injected
with interaction partner plus GFP mRNA as marker with those
injected with GFP mRNA only. N is the number of animals
investigated. (b) E4F1-injected larvae are immunostained to detect
pronephric tubule and duct using the antibodies 3G8 and 4A6 as
described.17 The upper panel is a dorsal view and the middle panel
gives lateral views (right and left) of the same larvae (animal 1). The
bottom panel represents the lateral views from a distinct individual
(animal 2). In all the lateral views, anterior is up and the injected
side is marked by an arrow. (c) Lateral views of a TRIM26-injected
larvae (animal 3) prepared as in (b). (d) ZFP36L1-injected larvae
prepared as in (b) with a dorsal view (top panel, animal 4) and
lateral views of three distinct larvae (animals 5–7). Bar¼ 500 and
200mm in the dorsal view and lateral views, respectively.
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distinct transcription factors,31,32 we additionally used the
artificial promoter HNF14-tk containing four HNF1-binding
sites linked to the thymidine kinase minimal promoter.33
But quite unexpectedly, E4F1 stimulated the artificial
promoter and therefore it remains open, whether E4F1
interferes by direct interaction with the transcriptional
activity of HNF1b.
In the case of ZFP36L1, a more conclusive interpretation
is possible (Figure 6b). Whereas the data with osteopontin and
Ksp-cadherin promoter do not reveal convincingly an
interaction of the transcription factors, as ZFP36L1 inhibits
the basal activity of both promoters, the HNF1b-mediated
activation of the artificial promoter HNF14-tk is partially
inhibited by cotransfecting ZFP36L1. As ZFP36L1 on its own
does not affect the HNF14-tk promoter, our data suggest that
interaction of ZFP36L1 with HNF1b mediates a reduction of
the transactivation potential of HNF1b.
As the transactivation experiments were performed in
HEK293 cells lacking HNF1b to avoid the interference with
the endogenous HNF1b, we cannot exclude that the result
would be different in differentiated kidney epithelial cells.
Molecular genetic analysis of the human ZFP36L1 gene
To investigate if mutations in the ZFP36L1 gene could cause
renal disease, we sequenced ZFP36L1 in 58 subjects with
unexplained renal disease. No mutations were identified;
however, the polymorphism rs1051533 was detected (allele
frequencies: GG 0.57, GT 0.38, TT 0.05).
DISCUSSION
Using the BacteriomatchII two-hybrid system, we identified
five novel interaction partners of HNF1b, from which four
were confirmed by GST pull-down assays. This shows that
the bacterial two-hybrid system, which so far has rarely been
used, is a reliable method. With the bacterial system, we also
identified PCDB1 (DCoH) to interact with HNF1b, an
interaction that has been previously identified by the yeast
two-hybrid system.34
To narrow down genes that may interfere with nephrogen-
esis, we overexpressed the corresponding proteins in the
developing Xenopus embryo. This assay is well suited for a
functional screen, as it has been used to document the
nephrogenic role of many transcription factors including
HNF1b,16 lim1,24,35 Osr1,36 and Pax2/Pax8.24,35 Significantly,
as shown for HNF1b,16,17 overexpression results in defective
pronephros development, although loss of function seems to
be the causative factor for the human disease.2,3 The
alternative approach to knock down the endogenous gene by
a morpholino oligonucleotide was not readily feasible as the
sequence of the corresponding Xenopus genes is not available.
The interaction partner HADH showed no effect on
pronephros development when overexpressed in Xenopus.
Nevertheless, there might be some interaction of biological
relevance in pancreatic b-cells where HNF1b represents the
MODY5 gene resulting in MODY537 caused by b-cell
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Figure 4 | Expression of HNF1b, ZFP36L1, and E4F1 in Xenopus embryos. (a) Whole-mount in situ hybridization of HNF1b, E4F1,
and ZFP36L1 in Xenopus neurula and tailbud embryos using antisense probes. HNF1b is predominantly expressed in the pronephros anlage
in neurula stage (arrow) as well as in the anlage of the pronephric tubule (arrow) and duct (arrow head) of the tailbud stage. Arrows
and arrow heads mark the pronephric tubule and duct anlage, respectively, observed in tailbud embryos probed with E4F1 or ZFP36L1.
ZFP36L1 is the Xenopus ortholog C3H-2. (b) Whole-mount in situ hybridizations with the corresponding sense probes.
E4F1 HNF1β Merge
ZFP36L1 HNF1β Merge
Figure 5 | Cellular localization of HNF1b and the interaction
partners E4F1 or ZFP36L1 in HEK293 cells. HEK293 cells were
transfected with 0.9 mg Rc/CMV-GFP-HNF1b and 0.9 mg
pCS2þmt-E4F1 or 0.9 mg Rc/CMV-GFP-HNF1b and 0.3 mg
pCS2þmt-ZFP36L1. HNF1b is visible by green fluorescence of the
GFP tag, whereas the myc-tagged E4F1 or ZFP36L1 is marked by a
Cy3-coupled secondary antibody. Right panels are overlays of
confocal microscopy.
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dysfunction. It is known that HADH plays a role in insulin
secretion as well, as mutations are responsible for congenital
hyperinsulinism.38 Possibly, the function of HADH and
HNF1b on insulin secretion is linked by interaction of the
two proteins in b-cells of the pancreas.
Our data show that overexpression of either E4F1 or
ZFP36L1 interfered with nephrogenesis by affecting both the
size of the pronephros as well as the morphology. This is
consistent with our observation that both of these interaction
partners of HNF1b colocalize with HNF1b in the differ-
entiating pronephros of the Xenopus tailbud-stage embryo
(Figure 4). According to the GUDMAP (Genito Urinary
Development Molecular Anatomy Project, http://www.
gudmap.org), E4F1 (GUDMAP: 5868) and ZFP36L1
(GUDMAP: 6569 and 6570) are expressed in most cell types
of the developing metanephros of the mouse, whereas
HNF1b (GUDMAP: 5794) expression is restricted to the
early and late tubules. Thus, in the tubules of the developing
mouse metanephros, an interaction of these transcription
factors is possible. Owing to limited specificity of antibodies
and unspecific interactions, we could not prove that the
interactions found in vitro indeed occur in vivo. However,
our data establish that at least two of the factors identified as
interaction partner of HNF1b affect nephrogenesis in the
developing Xenopus embryo.
E4F1 is a transcription factor, which contains 10 C2H2
type zinc fingers, of whom two are located in the C-terminal
region that is bound in our two-hybrid system by HNF1b.
E4F1 knockout mice are not informative for a role in kidney
development, as they die during peri-implantation stage.
Overexpression in Xenopus embryos reveals an enlargement
of the pronephros caused by both lengthening and thickening
of tubules and duct (Figure 3). We speculate that this reflects
increased cell division, as E4F1 is a regulator of cell
proliferation. As E4F1 modifies chromatin-associated p5339
and interacts with the Polycomb group complex of the
chromatin,40 it is possible that E4F1 and HNF1b, colocalized
in dot-like structures in the nucleus (Figure 5), cooperate on
the chromatin level. Such epigenetic processes usually cannot
be identified in nonintegrated reporter genes and may
explain the lack of an effect of E4F1 on HNF1b function in
reporter gene assays (Figure 6a).
As E4F1 is located on chromosome 16p13.3 about 90 kb
upstream of the PKD1 (polycystic kidney disease 1) gene, it is
possible that some congenital kidney malformations that
have been linked to PKD1 could in fact represent a defective
E4F1 gene.
The other protein affecting the size and morphology of the
pronephros is ZFP36L1. It belongs to the tristetraprolin
family of CCCH zinc finger proteins and shuttles between
nucleus and cytoplasm.41 Whereas its nuclear function is
unknown, its role in the cytoplasm has been extensively
studied. It binds to AU-rich elements in 30UTR of mRNAs
and initiates their degradation by recruiting RNA decay
enzymes bound to the N-terminus of ZFP36L1.42 In our
study, the C-terminus of ZFP36L1 interacted with HNF1b,
and in this domain, the nuclear export signal is localized41
that might be influenced by binding of HNF1b.
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Figure 6 | The effect of E4F1 and ZFP36L1 on the transactivation potential of HNF1b. HEK293 cells were transfected with the
luciferase reporter construct driven by the osteopontin (OPN), Ksp-cadherin or the artificial promoter containing four HNF1-binding site
linked to the tk promoter (HNF14-tk). The expression vector Rc/CMV-HNF1b and either (a) pCS2þmt-E4F1 or (b) pCS2þmt-ZFP36L1 were
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from a least six measurements are given and significant activation (P-value o0.05) by the transcription factors alone are indicated by
the corresponding P-value. The bracket in B indicates the significant downregulation by ZFP36L1 (P-value 1.9 105). The ACE231 and
pkhd113 promoter were also affected by E4F1 and ZFP36L1 in the absence of HNF1b (data not shown).
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Although ZFP36L1 has been knocked out in mice, no
information of its role in nephrogenesis is possible, as a
dramatic perturbation of chorioallantoic fusion occurs leading
to death in utero. Thus, any abnormality observed in the fetus
may be secondary to placental failure.43 Previously, another
member of the tristetraprolin family, C3H-3b (a Xenopus gene
with no mammalian ortholog), was identified to be expressed
in the pronephros-surrounding tissue. As the knockdown as
well as the overexpression of C3H-3b lead to defective
pronephric development,44 it seems functionally similar to
C3H-2, the Xenopus ortholog of ZFP36L1. As it has recently
been found that ZFP36L1 can degrade vascular endothelial
growth factor mRNA,45 it is an attractive hypothesis that this
mRNA may be a relevant renal target, as proper vasculariza-
tion is crucial in nephrogenesis. However, we favor a nuclear
function, as we observed that ZFP36L1 reduces the HNF1b
transactivation potential on an artificial HNF14-tk promoter
with four HNF1b-binding sites (Figure 6b). Thus, ZFP36L1
may be able to downregulate HNF1b target genes by
protein–protein interaction. Interestingly, as the activity of
three natural promoters (osteopontin and Ksp-cadherin in
Figure 6 as well as the pkhd1,13 data not shown) were reduced
by ZFP36L1 in the absence of HNF1b, a function of ZFP36L1
in transcriptional control is most likely. We exclude a potential
effect on the stability of the luciferase mRNA, as the artificial
promoter HNF14-tk (Figure 6) as well as the ACE2 promoter
(data not shown) were not affected by ZFP36L1.
Based on our data, E4F1 and ZFP36L1 are both potential
CAKUT genes. To explore this assumption, we analyzed the
two coding exons of ZFP36L1 from 58 patients with
unexplained renal disease. As sequencing revealed no
mutation, we conclude that mutations in ORF of this gene
are rare. However, we cannot exclude full deletion of the
gene, as frequently observed for HNF1b,2,4 or some
mutations in this gene locus affecting gene expression.
Furthermore, epigenetic events that are major causes for the
inactivation of tumor-suppressor genes46 should be consid-
ered as well.
METHODS
Bacterial two-hybrid system
We used the BacteriomatchII two-hybrid system provided by
Stratagene and integrated the HNF1bbb segment24 (Figure 1b) into
the pBT vector. The target library was a human fetal kidney cDNA
library of five 17- to 28-week-old male fetuses provided by
Stratagene. Search for interaction partners was carried out as
described in the manual.
Plasmid constructions of interaction partners
Full-length open reading frames of the human interaction partners
were commercially obtained (E4F1: MHS 1011-98054328, Open
Biosystems, Huntsville, AL, USA; HADH: IRAUp969Eo716D6
RZPD, Heidelberg, Germany; DAK: IRATp970A075D6, RZPD;
TRIM26: EHS 1001-44147, Open Biosystems; ZFP36L1, IR-
ATp970B0216D6, RZPD) and cloned into pCS2þmt to generate
N-terminal myc-tag fusion proteins using appropriate primers.
Primer details are available upon request.
Plasmid construction for in situ hybridization
The cDNA sequence of Xenopus laevis homolog of ZFP36L1, C3H-2
(IRAKp961O21159Q2, RZPD), was cloned into pBluescript SKþ .
RNA was produced using T3 and T7 polymerase. As for E4F1, no
Xenopus laevis cDNA was available; the corresponding Xenopus
tropicalis cDNA was used (IRAKp961C23279Q, RZPD). RNA was
produced with SP6 and T7 polymerase.
GST pull-down assays
The open reading frame of HNF1bbb was cloned from pBT-
HNF1bbb into pGEX4T3 and fusion proteins were produced in E.
coli BL21 (Amersham Biosciences, Freiburg, Germany). After
binding of GST fusion proteins to glutathione sepharose beads
(Amersham Biosciences), beads were blocked with NETN (20 mM
Tris HCl pH 8, 100 mM NaCl, 1 mM EDTA, 0.4% NP40) containing
3% BSA. Interaction partners were produced using the TNT system
provided by Promega. A total of 10mg of GST-HNF1bbb or
equimolar amount of GST were incubated with 5 ml of TNT reaction
in NETN-containing protease inhibitor cocktail (Sigma, St Louis,
MO, USA) for 1 h at room temperature. After five washing steps,
beads were heated with Laemmli sample buffer to 951C for 4 min
and the supernatants were probed by Western blot analysis with
anti-myc antibody.
In vivo experiments
Xenopus embryo manipulations were done as described.24 Whole-
mount in situ hybridization was performed using the standard
technique with BM purple staining.47 Cell transfection and
luciferase assays in Flp In T-Rex 293 cells (Invitrogen) have been
described.31
Subjects
Fifty-eight subjects with unexplained renal disease were recruited as
described.1 All subjects are negative for an HNF1b mutation or
deletion. The cohort was diagnosed with renal dysplasia 12/58, renal
malformations 12/58, atypical familial juvenile hyperuricaemic
nephropathy 1/58, glomerulocystic kidney disease 5/58, and renal
cysts 28/58, eighteen of which had diabetes (11 with the renal cysts
and diabetes syndrome). The study was approved by the local Ethics
Committee, and informed consent was obtained from each subject.
Molecular genetic analysis of the ZFP36L1 gene
The entire coding region and intron–exon boundaries of the ZFP36L1
gene were amplified by PCR using genomic DNA and sequence-
specific primers (primer details available on request). Forward-strand
sequencing using the Big Dye Terminator Cycler Sequencing Kit
(Applied Biosystems, Warrington, UK). Reactions were analyzed on an
ABI 3730 Capillary DNA sequencer (Applied Biosystems). Sequences
were compared with the published sequence (NM_004926) using
Mutation Surveyor Software (www.softgenetics.com).
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